Phebe Novakovic
Analyst · UBS
Thanks, Erin. Earlier today we reported fourth quarter earnings from continuing operations of $2.19 per fully diluted share on revenue of $8.36 billion and earnings from continuing operations of $737 million. It was our strongest revenue performance in the past 12 quarters, the highest operating earnings ever and the highest earnings from continuing operations. For the year we had fully diluted earnings per share of $7.83 on revenue of $30.85 billion and earnings from continuing operations of $2.7 billion, a return on sales of 8.7%. It was a year of solid achievement from both an operating perspective and the development of significant backlog. As you can see from schedule H to the press release, funded backlog grew from $38.3 billion at year end 2013 to $52.9 billion at the end of last year. The story for total backlog is much the same. We were at $45.9 billion at the end of 2013 and sit at $72.4 billion at the end of 2014. As a result, we are well positioned for growth in 2016 and 2017. Free cash flow from operations was a negative $254 million in the quarter. However for the year we had free cash flow from operations of $3.2 billion or 123% of earnings from continuing operations. This outpaced 2013 by 532 million. Let me give you some detail on the quarter and the year in each of the business groups. First, aerospace. Revenue and earnings were up nicely over the year ago quarter. Sales were up 105 million, 4.9% and earnings were up 64 million, a significant 18.4% on very strong margin improvement. This is particularly impressive when one considers that G&A and net R&D were up $40 million over the year ago quarter. On a sequential basis, sales were up $49 million but earnings were up 1 million on a 40 basis point improvement in operating margins. I should add that Jet remained nicely profitable in the quarter with a better contribution on both a year ago and sequential comparison basis. The order activity in the quarter was robust as one would expect with the announcement of two new aircraft. As you can observe, on Exhibit H, funded backlog – total backlog and total potential contract value, including options are all up significantly. Even if we were to ignore the orders related to the two new aircraft, total orders from current production aircraft were the highest of the year. All large cabin aircraft had a dollar based book to bill greater than 1 to 1. For the year, revenues were 8.65 billion in operating earnings or 1.61 billion on an operating margin of 18.6%. This is a year over year improvement of 6.5% on sales, 13.8% on earnings and 120 basis points on operating margin. All in all, a very good year at aerospace with strong operating leverage. At combat systems, sales were up 23 million or 1.4% and earnings were up 21 million or 8.4%, on a 110 basis point improvement in operating margin over the year ago quarter. Sequentially the story is similar. Sales were up 219 million and earnings were up 39 million. For the year sales were down 100 million or 1.7% and earnings were down 46 million or 5.1%. This compares quite favourably to the guidance we provided at this time last year. You may recall that we guided to a 4 to 4.5. Revenue declined as opposed to the 1.7% decline that occurred. We also guided the operating margins of 14% which we beat by 100 basis points. Overall combat systems is a story of solid additions to backlog, better than anticipated revenue and outstanding cost and margin performance. This is a business group that has clearly stabilized. Margin group revenue in the quarter exceeded $2 billion for the first time ever. Operating earnings of 193 million were the second highest ever recorded. Revenue was up 410 million or 25.2% compared to the year ago quarter and up 220 million or 12.1% sequentially. Revenues for the year were up 600 million, almost 9%, very nice growth. Operating earnings were up 34 million or 21.4% against the year ago quarter and up 23 million or 13.5% sequentially. For the full year, earnings were up 37 million or 5.6% on a 30 basis point decline in operating margins, attributable to mix shift which was consistent with our guidance to you. In the marine group, we guided you at this time last year to a revenue increase of 2.5% which we obviously exceeded. We forecasted margins at 9.5% and wound up at 9.6%, all in all a very good year for the marine group. IS&T is a business group where we saw less than expected revenue decline and improved operating performance. Revenue in the quarter was 2.47 billion, down 223 million or 8.3% against the year ago quarter. Revenue was up 9.8% sequentially and down 1.1 billion or 10.8% for the year. Remember that this is dramatically less than the 20% revenue decline we forecasted in our guidance to you at this time last year. Operating earnings of 212 million in the quarter were 8.2% better than the fourth quarter a year ago. On a sequential basis, operating earnings were up 10 million or 5%. For the year, earnings were down only 10 million or 1.3%, which is very good performance in the face of a 10.8% revenue decline. On this call a year ago, I gave you guidance with respect to operating margins in the 8.2% range which we beat by 40 basis points. All in all, we beat forecasted revenue by $1 billion and operating margins by 40 basis points. When that happens, the result is a very pleasant upside surprise. So company wide, on this call a year ago, our guidance for 2014 was to expect revenues of 30 billion, operating margin rate of 12%, a tax rate of 31% and the return on sales of 8%. We wound up the year with revenues of 30.85 billion, an operating margin rate of 12.6%, an effective tax rate of 29.7% and a return on sales of 8.7%. We provided EPS guidance of $6.80 to $6.85. We wound up at $7.83. About $0.62 of the improvement came from better than planned operating performance, $0.13 from slightly lower than planned tax rate and the balance from share count as a result of share repurchases. So let me provide you some thoughts about 2015, initially by business group and then on a company wide roll-up. In aerospace, we expect revenues to be approximately 9.4 billion, up about 8.3%. Margin rate should be approximately 18%, somewhat down from 2014 attributable in part to less favorability at Jet. Nonetheless up about 4.5% in earnings. In combat systems, we expect both revenue and earnings to be essentially flat with growth resuming in 2016 and beyond. The marine group is expected to have revenue growth of 2% to 2.5% and a margin rate in the 9.5% range, resulting in a very modest improvement to operating earnings. Finally, in IS&T, we expect a revenue decline of about 5.5% but improved margin rate of slightly more than 9%. This will result in improved operating earnings year over year. We expect the last year to be our low watermark for revenue. In part, we are seeing some of the decline we anticipated last year being delayed into this year. Once again we should see revenue growth in 2016 and 2017. All of this rolls up to an operating plan of about $31.3 billion to $31.5 billion of revenue, EBIT rate around 12.8% and a return on sales of roughly 8.7%. This plan is purely from operations, assumes a 30.5% tax rate, assumes we buy enough shares to hold the share count steady with year end figures so as not to permit dilution from option exercise. This rolls up to an EPS guidance of $8.05 to $8.10 per fully diluted share. This compares with last year’s guidance of $6.80 to $6.85 at the same time on the same basis. So much like last year, beating our guidance must come from out-performing the operating plan and the effect of share repurchases. So how should one think about the quarterly progression of EPS? Whatever your model is for the year, divide by 4. And the first and the second quarters will be light by about $0.10, the third quarter about right on and the fourth quarter about $0.20 better. By the way, quarterly progression is notoriously difficult. With respect to capital deployment, we anticipate using all of our free cash flow in 2015 for dividends and share repurchases. While we don’t anticipate a robust year from a free cash flow perspective, in light of the advance payments on international orders that we have received last year, we intend to treat the free cash available for dividends and share repurchases on some normalized basis. In short, we will use balance sheet as necessary to normalize the year. I would now like to turn the call over to our Chief Financial Officer Jason Aiken.